Trial Profile
A phase II trial of brief duration combination chemotherapy and rituximab with prophylactic pegfilgrastim, followed by maintenance rituximab, in elderly/poor performance status patients with large B-cell non-Hodgkin's lymphoma.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 03 Nov 2021
Price :
$35
*
At a glance
- Drugs Rituximab (Primary) ; Cyclophosphamide; Mitoxantrone; Prednisone; Vincristine
- Indications B-cell lymphoma
- Focus Therapeutic Use
- 02 May 2011 Actual end date (Feb 2010) added as reported by ClinicalTrials.gov.
- 02 May 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 02 Oct 2007 Status changed from recruiting to in progress.